Aldeyra Therapeutics (ALDX) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.28
-0.21
-0.13
-0.06

Details

Expected EPS
-0.0975
Actual EPS
-0.06
Surprise EPS
0.04
Surprise Percent
+38.46%

Description

⁨Aldeyra Therapeutics⁩ (⁦ALDX⁩) has reported earnings of ⁦-0.06⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts